UPDATE 1-Athersys stem-cell therapy for bowel disease fails in trial

Athersys Inc said its experimental stem-cell therapy for treating an inflammatory bowel disease failed to show any meaningful benefit in early results from a trial, sending its shares plunging 57 percent before the bell.

http://ift.tt/1nVEQOg